clinicaltrials.gov dihexa Lexeo Therapeutics shared an update on LX2006, an investigational gene therapy for Friedreich's Ataxia cardiomyopathy. The therapy is currently being studied in an ongoing Phase 1/2 trial, with data helping to inform Size:30-Day Supply fda bpc-157 category 2 Best Injectable Vitamin for Pets
SKU: 74903991618
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9



















